24/7 Market News Snapshot 08 September, 2025 – Microbot Medical, Inc. Common Stock (NASDAQ:MBOT)

September 8, 2025

DENVER, Colo., 08 September, 2025 (www.247marketnews.com) – (NASDAQ:MBOT) are discussed in this article.
Microbot Medical, Inc. (NASDAQ:MBOT) is experiencing a notable bullish trend, with shares currently trading at $3.973, reflecting an increase of 8.55% from the previous session. The heightened trading volume of 13.41 million shares signals robust investor interest and momentum, potentially linked to significant recent developments within the company.

The recent FDA 510(k) clearance for Microbot’s LIBERTY® Endovascular Robotic System marks a pivotal advance in the field of endovascular robotics. This pivotal innovation makes LIBERTY® the first single-use, remotely operated robotic system cleared by the FDA for peripheral endovascular procedures, addressing critical efficiency and accessibility needs in healthcare. With the U.S. market accounting for approximately 2.5 million of these procedures annually, Microbot is strategically positioned to leverage this substantial opportunity.

Harel Gadot, Chairman, CEO, and President of Microbot, stated, “Achieving FDA 510(k) clearance is a transformative moment for Microbot Medical and reflects our commitment to expanding access to pioneering robotic technologies.” The company is now eager to expedite its market entry following this clearance, having been proactively developing its commercialization strategy in recent months.

The pivotal study of the LIBERTY® system yielded remarkable results, showcasing a 100% success rate in navigating to targets and zero device-related adverse events. Additionally, physicians noted a significant 92% reduction in their radiation exposure, greatly improving safety and ergonomics during procedures.

Microbot Medical will highlight its recent accomplishments and plans at the H.C. Wainwright Annual Investor Conference on September 9, 2025, during a live webcast presentation scheduled for 9 AM ET. This gathering will serve as an essential platform for exchange among investors and stakeholders about the transformative potential of the LIBERTY® System and its anticipated impact on endovascular care, showcasing Microbot’s vision for enhancing patient outcomes through advanced robotics in the medical device industry.

Related news for (MBOT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.